Scientists are expected to present new data today about rates of co-infections with SARS-CoV-2, influenza, and respiratory syncytial virus (RSV), offering one of the first snapshots of the interplay among these common but potentially deadly viruses.
Announced on July 25, 2023, the research included results from more than 26,000 respiratory tests of U.S. adults and children in late 2022 and found co-infections in more than 1% of positive samples.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
